Rodríguez-Nóvoa S - Search Results

1

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

Rallón NI, Morello J, Labarga P, Benito JM, Rodríguez-Nóvoa S, Vispo E, Barreiro P, Castro MÁ, Aguirrebengoa K, Pineda JA, Miralles P, Tellez MJ, Portu J, Miralles C, Ocampo A, Soriano V; Peginterferon Ribavirin Coinfection Team. Rallón NI, et al. Clin Infect Dis. 2011 Dec;53(12):1291-5. doi: 10.1093/cid/cir665. Epub 2011 Oct 25. Clin Infect Dis. 2011. PMID: 22028438

2

Combinations of nucleoside/nucleotide analogues for HIV therapy.

Barreiro P, García-Benayas T, Rendón A, Rodríguez-Novoa S, Soriano V. Barreiro P, et al. AIDS Rev. 2004 Oct-Dec;6(4):234-43. AIDS Rev. 2004. PMID: 15700622 Review.

3

Atazanavir: the advent of a new generation of more convenient protease inhibitors.

Barreiro P, Rendón A, Rodríguez-Nóvoa S, Soriano V. Barreiro P, et al. HIV Clin Trials. 2005 Jan-Feb;6(1):50-61. doi: 10.1310/NBL2-R2G6-6V09-LL4C. HIV Clin Trials. 2005. PMID: 15765311 Review.

4

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

Rodriguez-Novoa S, Barreiro P, Rendón A, Jiménez-Nacher I, González-Lahoz J, Soriano V. Rodriguez-Novoa S, et al. Clin Infect Dis. 2005 May 1;40(9):1358-61. doi: 10.1086/429327. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825040

5

Pharmacogenetics in HIV therapy.

Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nacher I, Rendón A, Soriano V. Rodríguez-Nóvoa S, et al. AIDS Rev. 2005 Apr-Jun;7(2):103-12. AIDS Rev. 2005. PMID: 16092504 Review.

6

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

Rodríguez Nóvoa S, Barreiro P, Rendón A, Barrios A, Corral A, Jiménez-Nacher I, González-Lahoz J, Soriano V. Rodríguez Nóvoa S, et al. Clin Infect Dis. 2006 Jan 15;42(2):291-5. doi: 10.1086/499056. Epub 2005 Dec 8. Clin Infect Dis. 2006. PMID: 16355344

7

Overview of the pharmacogenetics of HIV therapy.

Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nácher I, Soriano V. Rodríguez-Nóvoa S, et al. Pharmacogenomics J. 2006 Jul-Aug;6(4):234-45. doi: 10.1038/sj.tpj.6500374. Epub 2006 Feb 7. Pharmacogenomics J. 2006. PMID: 16462814 Review.

8

Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

García-Benayas T, Rendón AL, Rodríguez-Novóa S, Barrios A, Maida I, Blanco F, Barreiro P, Rivas P, González-Lahoz J, Soriano V. García-Benayas T, et al. AIDS Res Hum Retroviruses. 2006 Apr;22(4):333-7. doi: 10.1089/aid.2006.22.333. AIDS Res Hum Retroviruses. 2006. PMID: 16623636

9

Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.

Rodríguez-Nóvoa S, Martín-Carbonero L, Barreiro P, González-Pardo G, Jiménez-Nácher I, González-Lahoz J, Soriano V. Rodríguez-Nóvoa S, et al. AIDS. 2007 Jan 2;21(1):41-6. doi: 10.1097/QAD.0b013e328011d7c1. AIDS. 2007. PMID: 17148966

10

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy.

de Mendoza C, Martin-Carbonero L, Barreiro P, de Baar M, Zahonero N, Rodriguez-Novoa S, Benito JM, González-Lahoz J, Soriano V. de Mendoza C, et al. AIDS. 2007 Mar 12;21(5):583-8. doi: 10.1097/QAD.0b013e32805e8742. AIDS. 2007. PMID: 17314520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page